Evergreening: How Pharma Companies Use Patent Loopholes to Block Generic Drugs
Evergreening lets pharmaceutical companies extend drug patents with minor changes, blocking cheaper generics and keeping prices high. Learn how it works, why it hurts patients, and who’s fighting back.
Continue reading...
